You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia in Chronic Phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    Jan 17, 2023

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

      Recruiting
      • Olverembatinib
      • +2 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Jul 26, 2022

      Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis
        Nov 20, 2023

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Withdrawal;Drug
        • Imatinib withdrawal
        • +2 more
        • Brno, Czechia
        • +7 more
        Aug 24, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

        Recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 31, 2022

        Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

        Recruiting
        • Chronic Myeloid Leukemia in Myeloid Blast Crisis
        • +3 more
        • based decitabine and olverembatinib（HQP1351)chemotherapy
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Dec 6, 2022

        Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Nilotinib
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Mar 15, 2022

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

        Recruiting
        • CML, Chronic Phase
        • CML, Accelerated Phase
        • HS-10382(Part 1: Dose escalation)
        • HS-10382(Part 2: Dose expansion)
        • Wuhan, Hubei, China
          Union Hospital affiliated to Tongji Medical College of Huazhong
        Jan 12, 2023

        MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

        Not yet recruiting
        • Myelodysplastic Syndromes
        • +3 more
        • Subcutaneous azacitidine
        • Oral decitabine/cedazuridine
        • Newcastle, New South Wales, Australia
          Calvary Mater Newcastle
        May 29, 2023

        Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

        Active, not recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Beijing, China
          Peking University People's Hospital(北京大学人民医院)
        Jan 3, 2022

        Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

        Recruiting
        • Myelofibrosis
        • +2 more
        • Charlottesville, Virginia
          Danyelle Coley
        Jan 18, 2023

        Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

        Not yet recruiting
        • Myelodysplastic Syndrome
        • +4 more
        • UAE Inhibitor TAK-243
        • (no location specified)
        Oct 20, 2022

        Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +9 more
        • Los Angeles, California
        • +5 more
        Jan 27, 2023

        Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

        Recruiting
        • Acute Biphenotypic Leukemia
        • +13 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 19, 2023

        Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

        Not yet recruiting
        • Chronic Myelogenous Leukemia
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        Oct 12, 2023

        Metabolic Alternation and Clinicohematological Characteristic in

        Not yet recruiting
        • CML, Chronic Phase
        • Tyrosine kinase inhibitor
        • (no location specified)
        Nov 6, 2023

        Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)

        Recruiting
        • Flumatinib
        • +2 more
        • Shenzhen, Guangdong, China
          The Second People's Hospital of Shenzhen
        Mar 15, 2022

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +2 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 15, 2022